Paper39669588
Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes.
Agaoglu NB and 11 others. Genet Med Open, 2024. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes. Papers, record 39669588. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39669588
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24800916 | Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations. | Breast Cancer Res Treat | 2014 | https://conductscience.org/library/papers/24800916 | PubMed |
| 2 | 36003761 | Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/36003761 | PubMed |
| 3 | 22535016 | Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22535016 | PubMed |
| 4 | 31993860 | High risk of breast cancer in women with biallelic pathogenic variants in CHEK2. | Breast Cancer Res Treat | 2020 | https://conductscience.org/library/papers/31993860 | PubMed |
| 5 | 20091130 | Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain. | Fam Cancer | 2010 | https://conductscience.org/library/papers/20091130 | PubMed |
| 6 | 29153097 | Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories. | Cancer Genet | 2017 | https://conductscience.org/library/papers/29153097 | PubMed |
| 7 | 10733235 | Assessment of education and counselling offered by a familial colorectal cancer clinic. | Clin Genet | 2000 | https://conductscience.org/library/papers/10733235 | PubMed |
| 8 | 31406321 | A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients. | Genet Med | 2020 | https://conductscience.org/library/papers/31406321 | PubMed |
| 9 | 31201024 | Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines. | J Mol Diagn | 2019 | https://conductscience.org/library/papers/31201024 | PubMed |
| 10 | 21075289 | Mouse models of inherited cancer syndromes. | Hematol Oncol Clin North Am | 2010 | https://conductscience.org/library/papers/21075289 | PubMed |
| 11 | 18246448 | Inequality of use of cancer genetics services by members of breast, ovarian and colorectal cancer families in South East Scotland. | Fam Cancer | 2008 | https://conductscience.org/library/papers/18246448 | PubMed |
| 12 | 32948847 | Barriers and facilitators for cascade testing in genetic conditions: a systematic review. | Eur J Hum Genet | 2020 | https://conductscience.org/library/papers/32948847 | PubMed |
| 13 | 21921926 | Haplotype phasing: existing methods and new developments. | Nat Rev Genet | 2011 | https://conductscience.org/library/papers/21921926 | PubMed |
| 14 | 27836010 | Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. | Breast Cancer Res | 2016 | https://conductscience.org/library/papers/27836010 | PubMed |
| 15 | 32743790 | Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals. | Fam Cancer | 2021 | https://conductscience.org/library/papers/32743790 | PubMed |
| 16 | 34875721 | Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics. | Cancer | 2022 | https://conductscience.org/library/papers/34875721 | PubMed |
| 17 | 32777875 | Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with BRCA1 or BRCA2 Mutation. | Cancer Res Treat | 2021 | https://conductscience.org/library/papers/32777875 | PubMed |
| 18 | 36136322 | Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2. | JAMA Oncol | 2022 | https://conductscience.org/library/papers/36136322 | PubMed |
| 19 | 34637943 | Concurrent pathogenic variations in patients with hereditary cancer syndromes. | Eur J Med Genet | 2021 | https://conductscience.org/library/papers/34637943 | PubMed |
| 20 | 25741868 | Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. | Genet Med | 2015 | https://conductscience.org/library/papers/25741868 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42258060 | Characterization of the molecular and clinical features of Multilocus Inherited Neoplasia Allelic Syndrome (MINAS) cases in the Turkish population. | Fam Cancer | 2026 | https://conductscience.org/library/papers/42258060 | PubMed |
| 41487526 | Multilocus inherited neoplasia allele syndrome (MINAS) in a Turkish cohort: molecular insights and clinical relevance for precision oncology. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41487526 | PubMed |
| 41228253 | Advances in Hereditary Colorectal Cancer: How Precision Medicine Is Changing the Game. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41228253 | PubMed |
| 40943312 | Double Pathogenic or Likely Pathogenic Variants in Cancer Predisposition Genes in Hungarian Cancer Patients. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943312 | PubMed |
| 39594831 | Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39594831 | PubMed |
| 39539798 | Hereditary and clinical insights into paraganglioma and pheochromocytoma. | Endocr Oncol | 2024 | https://conductscience.org/library/papers/39539798 | PubMed |
| 39353430 | Phenotypic spectrum of dual diagnoses in developmental disorders. | Am J Hum Genet | 2024 | https://conductscience.org/library/papers/39353430 | PubMed |
| 39317201 | Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants. | Am J Hum Genet | 2024 | https://conductscience.org/library/papers/39317201 | PubMed |
| 38985133 | Genotype matters: Personalized screening recommendations for germline CHEK2 variants. | Oncotarget | 2024 | https://conductscience.org/library/papers/38985133 | PubMed |
| 38854136 | Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants. | medRxiv | 2024 | https://conductscience.org/library/papers/38854136 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| CHEK2 | 11200 | PubTator's text mining | https://conductscience.org/library/genes/11200 | NCBI Gene |
| PALB2 | 79728 | PubTator's text mining | https://conductscience.org/library/genes/79728 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39669588
GET https://conductscience.org/api/papers/v1/39669588/authors